MicroRNA‐1307‐3p contributes to breast cancer progression through PRM2

MicroRNA‐1307‐3p contributes to breast cancer progression through PRM2

Abstract Background Despite advances in screening and therapy, breast cancer (BC) remains the predominant cancer in women globally. Dysregulation of microRNAs (miRNAs) is pivotal in carcinogenesis across various cancers, including BC. Evidence indicates that miR‐1307‐3p is upregulated in BC tumors,...

Full description

Saved in:
Bibliographic Details
Main Authors: José Roberto Estupiñan‐Jiménez, Valeria Villarreal‐García, Vianey Gonzalez‐Villasana, Pablo E. Vivas‐Mejia, Jose Manuel Vazquez‐Guillen, Patricio Adrián Zapata‐Morin, Marienid Flores‐Colón, Claudia Altamirano‐Torres, Ezequiel Viveros‐Valdez, Cristina Ivan, Mohammed H. Rashed, Recep Bayraktar, Cristina Rodríguez‐Padilla, Gabriel Lopez‐Berestein, Diana Resendez‐Perez
Format: Article
Language:English
Published: Wiley 2024-11-01
Series:Thoracic Cancer
Subjects:
breast cancer
cancer progression
microRNAs
miR‐1307‐3p
protamine 2
Online Access:https://doi.org/10.1111/1759-7714.15460
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1111/1759-7714.15460

Similar Items